Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bluebird bio
5
×
boston blog main
boston top stories
clinical trials
gene therapy
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san francisco blog main
beta-thalassemia
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
hemophilia
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agios pharmaceuticals
american society of hematology
biomarin pharmaceutical
biotech
cancer
cooley's anemia foundation
deals
What
american
ash
blood
diego
drug
gathering
gene
largest
long
medical
san
society
therapy
age
ago
annual
aren’t
big
bigger
biggest
bio
biotechs
borne
cancers
come
conference
considering
country
data
deal
developers
disease
diseases
drugs
dyne
early
emerging
expected
experimental
eyes
Language
unset
Current search:
" bluebird bio "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More